Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Arcutis Biotherapeutics, Inc. (ARQT)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arcutis Biotherapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Arcutis Biotherapeutics, Inc. since 2005.
The reporting company's ticker symbol is ARQT. The reporting company's CIK number is 1787306.
The total value of stock buying since 2005 is $41,002,181.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2020-02-04||Schwartz Jeffrey Lawrence (10% Owner)||Buy||294,117||17.00||4,999,989|
|2020-02-04||Heron Patrick J (Director)||Buy||500,000||17.00||8,500,000|
|2020-02-04||Topper James N (10% Owner)||Buy||500,000||17.00||8,500,000|
|2020-02-03||Orbimed Capital Gp Vii Llc||Buy||558,888||17.00||9,501,096|
Insider trading activities including stock purchases, stock sales, and option exercises of ARQT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arcutis Biotherapeutics, Inc. (symbol ARQT, CIK number 1787306) see the Securities and Exchange Commission (SEC) website.